Opinion & analysis

A World Without Rebates: Is FDA’s Gottlieb Offering New Vision?

Will drug rebates become illegal? U.S. FDA Commissioner Scott Gottlieb has suggested as much, and PBMs, among others, are paying close attention. Explore the implications–especially for PBMs–and find out why this is historically such a hot-button policy issue.

Get a more in-depth analysis on Pharmaceutical market trends with our Opinion on Analysis reports.

A World Without Rebates: Is FDA’s Gottlieb Offering New Vision?

2018’s Top Biopharma Deal-makers

EU Beats Predicted Timelines And Appoints First UK Notified Body Against MDR

AbbVie’s Skyrizi Poised To Enter Packed Psoriasis Market

Reckitt Shaking Up Brain Health Market With Neuriva Dietary Supplement And Mobile App Launch In US

Cell And Gene Therapy Logistics Requires Early Planning

Peter Stein Takes Short Path To Director Of US FDA Drug Office

US FDA May Largely Avoid House Democrats’ Investigation Agenda

Telehealth, Wearables and Apps – Report 3

Analysts Weigh Up Benefits Of Big Bayer Restructuring

Pharma Intelligence Report Store Article Collection Innovation, Data and Machine Learning Report 1

Novartis Pruned Pipeline Producing Attractive Respiratory And Neurology Fruits

Verseon Playing The Long Game To Level Up Drug Discovery

Deals Shaping The Medical Industry, February 2019

Cannabis Industry Taking Legal Action Against EU Regulators Over CBD Novel Food Classification

Biosimilar Suffixes Appear Superfluous In Adverse Event Reporting

US FDA Looks To Standardize Premarketing Safety Assessments

No More Rebates: HHS Proposed Rule Revises AntiKickback Safe Harbor

The Case For Agile Innovation In Health Care

Culture Change At GSK: ‘We’re Doing What We Said We’d Do’

In Vivo’s Quick Guide To Gene Therapy

Schakowsky’s Loaded Cosmetics Bill Described as ‘Floor, Not a Ceiling’ for States to Build On

DECIEM, Truly ‘The Abnormal Beauty Company,’ Faces Uncertain Future

Eudamed – A Moving Target But On Track For March 2020 Partial Go-Live

Sanofi Releases Annual Drug Price Report Ahead Of Senate Hearing

IXICO Targets Go-To Status In Neuro Data Analytics Space

Engaging Patients and Navigating Laws: What To Consider When Developing Health Apps

Telehealth, Wearables and Apps – Report 2

Let’s Make A Deal: Sanofi Regeneron Extend A Hand On Praluent, Express Scripts Takes It

European Commission Highlights Medtech Notified Bodies Giving It Cause For Concern